NCT05589207View on ClinicalTrials.gov

Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion

RecruitingOBSERVATIONAL

Enrollment

232

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions

Carcinoma, Renal CellTumor ThrombusNeoplasm InvasivenessInferior Vena Cava Interruption

Interventions

DIAGNOSTIC_TEST

Vascular wall invaded

Inferior vena cava vascular wall is invaded according to pathologic examination on the postoperative tumor thrombus/ vascular wall specimen.

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER

NCT05589207 - Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion | Biotech Hunter | Biotech Hunter